Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
LY03015
/
Luye Group
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
LY03015
/
Luye Group
Enrollment open, Trial completion date, Trial primary completion date:
A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
(clinicaltrials.gov) - Apr 26, 2023
P1
, N=104, Recruiting,
Sponsor: Luye Pharma Group Ltd.
Not yet recruiting --> Recruiting | Trial completion date: Jul 2023 --> Oct 2023 | Trial primary completion date: Jan 2023 --> Oct 2023
|||
|||||||
LY03015
/
Luye Group
New P1 trial:
A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
(clinicaltrials.gov) - Feb 14, 2022
P1
, N=104, Not yet recruiting,
Sponsor: Luye Pharma Group Ltd.